BiotechTube

SP-102

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Lumbosacral Radicular Pain

Conditions

Lumbosacral Radicular Pain

Trial Timeline

Jul 13, 2018 → Mar 15, 2019

NCT ID
NCT03613662

About SP-102

SP-102 is a phase 2 stage product being developed by Scilex Holding for Lumbosacral Radicular Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT03613662. Target conditions include Lumbosacral Radicular Pain.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03613662Phase 2Completed

Competing Products

5 competing products in Lumbosacral Radicular Pain

See all competitors
ProductCompanyStageHype Score
VX-548 + PlaceboVertex PharmaceuticalsPhase 2
51
BIIB074 + PlaceboBiogenPhase 2
49
CNV1014802 + PlaceboBiogenPhase 2
49
BIIB074BiogenPhase 2
49
SP-102 + PlaceboScilex HoldingPhase 3
69

Other Products from Scilex Holding

Lidocaine 1.8% + PlaceboApproved
77
SP-102 + PlaceboPhase 3
69
SP-103 + PlaceboPhase 2
44
ZTlido (Lidocaine Topical System) 1.8% + Salonpas (Lidocaine Patch 4%) + Aspercreme (Lidocaine Patch 4%) + IcyHot (Lidocaine 4% + Menthol 1% Patch)Phase 1
25
lidocaine topical system 1.8% + lidocaine patch 5%Phase 1
25